Diabetes is a lifelong (chronic) disease and group of metabolic disorder. Which the main symptom associated with this disease is the high levels in blood for a long period. It can be categorized to the world’s major diseases considering that affects high population in earth and presents two main types i and ii. Diabetic is a chronic disease which affects global population from long time. “Diabetes mellitus”, is one of the most common non-communicable conditions worldwide. India faces several challenges in diabetes operation, including a rising frequence in civic and pastoral areas, lack of complaint mindfulness among the public, limited health care installations, high cost of treatment, sour glycaemic control and rising frequence of diabetic complications. Insulin remedy for diabetes is most generally delivered via subcutaneous injections, up to four times a day. Long- term insulin remedy, compounded by the invasive nature of its administration, has caused problems with patient compliance, eventually impacting patient issues. There’s an increase in the frequence of type 1diabetes also, but main cause of diabetic epidemic is type2 diabetes mellitus, which accounts for further than 90 percent of all diabetes cases. Type2 diabetes is a serious and common habitual complaint performing from a complex heritageterrain commerce along with other threat factors similar as rotundity and sedentary lifestyle. diabetes mellitus is a complaint occurs due to metabolic problems is most frequent encyclopedically. The main suggestion of diabetes mellitus is a hyperglycemia in blood which is due to unhappy pancreatic insulin stashing or low insulin- directed fostering of glucose by target cells. Diabetes mellitus can be varied into several types but the two major types are type 1 and type 2. For type 1 diabetes cases insulin renewal remedy is the backbone, for case with type 2 diabetes there must be a control diet and life revision in type 2 insulin is vital when blood glucose are unfit to control by nutritive remedy, physical exertion and other specifics for the cure of type 2 dm oral hypoglycemic agents are preferred. In type 1 new approaches like island transplantation and artificial pancreas were developed.


diabetes mellitus, diagnosis, cause, and treatment


  1. Afroj A Shaikh, M. K. (2022). Diabetes Mellitus is a disease. International journal of Research in pharmaceutical Science, 102-108.
  2. A Ahmad, K. A. (2017). ‘Causes, Complications and Management of Diabetes Mellitus’. Chronicle Journal of Food and Nutrition,, 1(1), 1-3.
  3. Jaakko Tuomilehto, J. L. (2001, May). Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. N Engl J Med, 1343-1350.
  4. Ali H Mokdad 1, E. S. (2003, Jan). Prevalence of obesity, diabetes, and obesity-related health risk factors,. JAMA, 289(1), 76-79.
  5. Association, A. D. (2010, Jan). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 33(Suppl 1): S62–S69, 33(1), 62-69.
  6. Verge CF, G. R. (1996). Predicting type 1 diabetes in First- degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2autoantibodies Diabetes. 45, 926-933.
  7. Association, A. D. (2014). Diagnosis and classification of diabetes mellitus.Diabetes care,1.
  8. Defronzo RA, B. R. (1997). Pathogenesis of NIDDM. International Textbook of Diabetes Mellitus, 635(71).
  9. Kumar CR., (1992). Basic Pathology, (5. Edition,) Prism PVT. Limited Bangalore, 569-587.
  10. Lillioja S, M. D. (1993). Insulin resistance And insulin secretory dysfunction as precursors of non–insulin–dependent diabetes. N Engl J Med,, 329, 1988-92.
  11. MI. H. (1993). Undiagnosed NIDDM, clinical and public health issues,. Diabetes Care,, 16, 642-52.
  12. Mooy JM, G. P., (1995). Prevalence and determinants of glucose intolerance in a Dutch population,. Diabetes Care, 18, 1270-73.
  13. Jun SK, Yoon YW.(2002). A new look at viruses in Type 1 diabetes, Diabetes/Metabolism Research and Reviews, 19: 8-31.
  14. Malecki MT, K. T. (2005). Type2 diabetes mellitus; from genes to disease. Pharmacological Reports, 57, 20-32.
  15. Sicree R, S. J. (2006). Diabetes and Impaired glucose Tolerance. Diabetes Atlas International Diabetes Federation,, 15-103.
  16. Roshan Kumar, P. S. (2020). A Review on Diabetes Mellitus : Type 1 and Type 2. World journal of pharmacy and Pharmaceutical sciences, 9(10), 838- 850.
  17. Ribeiro C, d. A. (2010). Effects of Moderate Intensity Physical Training in Neonatal Alloxan: Administered Rats. J Diabetes Metab., 1(107).
  18. Mungrue K, Roper LA, Chung T.(2011). Assessment of Weight Loss in the Management of Patients with Type 2 Diabetes Mellitus in Primary Care in Trinidad. J Diabetes Metab. 2(120)
  19. Ragheb R, M. A. (2011). Mechanisms of Fatty Acid- Induced Insulin Resistancein Muscle and Liver. J Diabetes Metab, 2(127).
  20. Lemos Costa TMR, D. J.-N.-M. (2011). Glycemic Variability and Mean Weekly Glucose in the Evaluation And Treatment of Blood Glucose in Gestational Diabetes Mellitus ; Evidence for Lower Neontal Complications. J Diabetes Metab, 2(137).
  21. Alina S, B. R. (2011). Elevation of selection Levels from 2-24 Months following Gestational Diabetesis Associated with Early Cardiometaboic risks in Non- Diabetic Women. J Diabetes Metab, 2(138).
  22. Fagninou Nonsito Adnette, N. T. (2019). Diabetes Mellitus: Classification, Epidermiology, Pathophysiology, Immunology, Risk Factors, Prevention and Nutrition. International Journal of Advanced Research,855-863.
  23. WHO. (1985). Definition, Diagnosis and Classification of Diabetes Mellitus & its complication :Report of a WHO Consultation. World Health Organization, 1-59.
  24. Hattersley., A. J. (2010). Monogenic Causes of Diabetes. Textbook of Diabetes, 243-264.
  25. Tyagi., n. C. (2018). Diabetes Mellitus: An Overview. International Journal of Research and Development in Pharmacy & Life Science, 7(4), 2278- 0238.
  26. Nishita Singh, Roohi Kesherwani, Arun Kumar Tiwari, Dilip Kumar Patel. (2016) ‘A review on diabetes mellitus’. The Pharma Innovation Journal 5(7), 36-40.
  27. Sawant Mayuri Rajesh, T. M. (2020). Review on Diabetes Mellitus: A Metabolic Disorder And One Of The Global challenge to world. World Journal of Pharmacy and Pharmaceutical sciences,, 10(9), 2018-2025.
  28. KAKU K. (2010). Pathophysiology of Type 2 Diabetes and. JMAJ, 53(1), 41-46.
  29. Af Amos, D. M. (1997). The rising global burden of diabetes and its Complications;estimates and projections to the year 2010. Diabetes Med, 14, 7-85.
  30. P George, B. R. (2000). Lipids and Diabetes. J Clin Biomed Sci, 3, 159-62.
  31. K. Harikumar, B. K. (2015). A Review on Diabetes Mellitus. International Journal of Novel Trained In Pharmaceuticals Sciences, 5(3), 201-217.
  32. Wilson., R. a. (2010). Anatomy and Pathophysiology in Health and Illness. (11, Ed.) Churshil Livingstone Elsevier, 227-229.
  33. Dattatreya Adapa, Sarangi TK (2015) ‘A Review on Diabetes Mellitus – Complications, Management and Treatment Modalities’. Research and Reviews: Journal of Medical and Health Sciences 4(3),
  34. Anjali B. Bargal, J. B. (2020). A review On complications and Mnagement of DIABETIC MALITUS’. ’ International Journal Of Creative Research Thoughts, 8(10), 137-144
  35. Dr. Arif Mohiddin. (2022) ‘Insulin and Diabetes Mellitus’. International journal of science and Research 11(1), 1299-1302.
  36. Jain, C. D. (2015). Diabetes Mellitus: A Review. International Journal of Pure & Applied Bioscience, 3(3), 224-230.
  37. Rajni Jain, P. J. (2016). ‘A Review on treatment and prevention of Diabetes Mellitus’. International Journal of current Pharmaceutical Research, 8(3), 16-18.
  38. Hossam., A. S. (2009). Diabetes mellitus. Researchgate, 1-10.
  39. Alastair J.J Wood, M.D., (1995) ‘Prevention and Treatment of the Complications of Diabetes Mellitus’. The New England Journal of Medicine 332(18), 1210- 1217.
  40. Mohd. Yaqub Khan. (2013) ‘A Review on Diabetes and Its Management’. Asian J. Pharm. Res 3(1), 28-33.
  41. Kaiser A, V. P. (2012). .Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the study. Diabetic Med.,, 29, 190-197.
  42. P.Vyshnavi1. (2022,). Review on diabetes mellitus. Journal of Innovations in Applied Pharmaceutical Science, 7(1), 24-27.
  43. Gupta OP, J. M. (1978). Prevalence of Diabetes In India. Advance Metab Disord, 9, 147-65.
  44. Diabetes. Diagnosis and Treatment. (2020). Mayo Clinic. Retrieved October 20, 2021
  45. Insulin Basics. (2021). American Diabetes Association. Retrieved 31 october 2021
  46. S Tyagi, C. J. (2013). Treatment and Management of Diabetes with Stem Cell Therapy: A Newer Scientific Approach. Jornal of Drug Discovery and Therapeutics,, 1(4), 2320-4230.
  47. Type 2 diabetes .(2019) Symptoms, Diagnosis, Treatment . Southern Cross, Last Reviewed: August 2019.
  48. Type 2 diabetes . Symptoms and Causes. 2021.Updated on: 20 Jan 2021.
  49. J M Gregory, D J Moore, and J H Simmons.(2021).Type 1 Diabetes Mellitus. Pediatrics in Review, 34(5):203–215.
  50. Skin Complications. American Diabetes association.(2021). Retrieved 3 Nov 2021.
  51. Selvin E, S. M. (2010). Glycated Haemoglobin, Diabetes, and Cardiovascular risk in nondiabetic adults. N. England. Med., 362(9), 800-11.
  52. Rahman, A. Z. (1989). Medicinal Plants with Hypoglycaemic activity. J Etnopharmacol, 26, 1-55.
  53. Modak, M. D. (2007). Indian Herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr, 40, 163-173.
  54. Saini A,Devidayal, Verma S, Bhalla AK (2011) Comparative Efficacy of Once Daily Insulin Glargine with Twice Daily NPH Insulin inchildren with Type 1 Diabetes. J Diabetes Metab,2(124).
  55. Alwan.(1994). Management of Diabetes Mellitus Standards of Care And Clinical Practice Guidelines. World Health Organization.
  56. M R Nagesh, N. Vijaykumar, and K Bhavani. (2020). A Review on Diabetes Mellitus- An Annihilatory Metabolic Disorder’. Journal of Pharmaceutical Sciences and Research, 12(2), 232-235.
  57. Deepthi B, S. L. (2017). A Modern review of Diabetes Mellitus: An Annihilatory Metabolic Disorder’. Journal of In Silico &min Vitro Pharmacology, 1(14), 1-5.

Manasi Patil
Corresponding author

M. S. College of Pharmacy, Devghar

Abraul Haque

M. S. College of Pharmacy, Devghar

Tanmaya Patil

M. S. College of Pharmacy, Devghar

Manasi Patil*, Abraul Haque, Tanmaya Patil, A Review On Diabetes Mellitus: Complications, Management And Treatment, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 11, 71-80.

More related articles
An Overview on Artificial Blood...
Rajnandini Ahire, Mukesh Ratnaparkhi, Shital Kshirsagar, Devang M...
Formulation And In vitro Evaluation Of Bilayer Tab...
Mayur Aware, Sheetal Gondkar, Rishikesh Bachhav, ...
A Comprehensive Review On Herbal Plants Showing An...
Saurabh Dumbre, Gaurav Gawade, Swati Jadhav, Pravin Khamkar, ...
Gastroretentive Drug Delivery System : A Review...
Suraj Kothule, Smita Aher, Rishikesh Bachhav, ...
Bilayer Floating Tablet : A Novel Floating Tablet...
Mayur Aware, Sheetal Gondkar, Rishikesh Bachhav, ...
Related Articles
Ayurvedic Remedies of Bacterial Meningitis...
Komal Ushir, Dinesh Rishipathak, Pragati Bhosale, Manisha Raut, ...
More related articles
An Overview on Artificial Blood...
Rajnandini Ahire, Mukesh Ratnaparkhi, Shital Kshirsagar, Devang Mahale, ...
A Comprehensive Review On Herbal Plants Showing Anti Diabetic Activity...
Saurabh Dumbre, Gaurav Gawade, Swati Jadhav, Pravin Khamkar, ...
An Overview on Artificial Blood...
Rajnandini Ahire, Mukesh Ratnaparkhi, Shital Kshirsagar, Devang Mahale, ...
A Comprehensive Review On Herbal Plants Showing Anti Diabetic Activity...
Saurabh Dumbre, Gaurav Gawade, Swati Jadhav, Pravin Khamkar, ...